Lactate Dehydrogenase-Elevating Virus Variants: Cosegregation of Neuropathogenicity and Impaired Capability for High Viremic Persistent Infection

References

• Anderson G. W., Even C., Rowland RRR, Palmer G. A., Harty J. T., Plagemann P. GW. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J Neurovirol 1995a; 1: 244–252
   PubMed Web of Science ®Google Scholar
• Anderson G. W., Palmer G. A., Rowland R.R.R., Even C., Plagemann P. GW. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in uteio infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol 1995b; 69: 308–319
   Google Scholar
• Anderson G. W., Palmer G. A., Rowland RRR, Even C., Plagemann P.G.W. Lactate dehydrogenase-ele-vating virus entry into central nervous system, and replication in anterior horn neurons. J Gen Virol 1995c; 76: 581–592
   Google Scholar
• Brinton-Darnell M., Plagemann P.G.W. Structural and chemical-physical characteristics of lactate dehy-drogenase-elevating virus and its RNA. J Virol 1975; 16: 420–433
   Google Scholar
• Chen Z., Plagemann P.G.W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cells. J Virol Meth 1997; 65: 227–236
   Google Scholar
• Chen Z., Li K., Plagemann P.G.W. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. J Neurovirol. 1998, Submitted.
   Google Scholar
• Chen Z., Rowland RRR, Anderson G. W., Plagemann P.G.W. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J Virol 1997; 71: 2913–2920
   Google Scholar
• Faaberg K. S., Plagemann P.G.W. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology 1995; 212: 512–525
   PubMed Web of Science ®Google Scholar
• Faaberg K. S., Even C., Palmer G. A., Plagemann P.G.W. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J Virol 1995; 69: 613–617
   PubMed Web of Science ®Google Scholar
• Godeny E. K., Chen L., Kumar S. N., Methven S. L., Koonin E. V., Brinton M. A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology 1993; 194: 585–596
   Google Scholar
• Lawrence C. B., Goldman D. A. Definition and identification of homology domains. CABIOS 1988; 4: 25–33
   PubMedGoogle Scholar
• Lai M.M.C., Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1–100
   PubMed Web of Science ®Google Scholar
• Li K., Chen Z., Plagemann P.G.W. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology 1998; 242: 239–245
   PubMed Web of Science ®Google Scholar
• Martinez D., Brinton M. D., Tachovsky T. G., Phelps A. H. Identification of lactate dehydrogenase-elevating virus as etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice. Infect Jmmun 1980; 27: 979–987
   Google Scholar
• Murphy W. H., Mazur J. J., Fulton S. A. Animal model for motor neuron disease. Clinical Neuroimmunology, WMH Behan, PO Behan, JA Aarli. Blackwell Scientific Publications, OxfordEngland 1987; 135–155
   Google Scholar
• Murphy W. H., Nawrocki J. F., Pease L. R. Age-dependent paralytic viral infection in C58 mice: Possible implication in human neurologic disease. Prog Brain Res 1983; 59: 291–303
   Google Scholar
• Nawrocki J. F., Pease L. R., Murphy W. H. Etiologic role of lactate dehydrogenase-elevating virus infection in an age-dependent neuropathic disease in C58 mice. Virology 1980; 103: 259–264
   Google Scholar
• Palmer G. A., Kuo L., Chen Z., Faaberg K. S., Plagemann P.G.W. Sequence of genome of lactate dehydrogenase-elevating virus. Heterogeneity between strains P and C. Virology 1995; 209: 637–642
   Google Scholar
• Plagemann PGW. Lactate dehydrogenase-elevating virus and related viruses. Virology, 3rd edition, BN Fields, DM Knipe, PM Howley. Raven Press, New York 1996; 1105–1120
   Google Scholar
• Plagemann P.G.W., Gregory K. F., Swim H. E., Chan K. KW. Plasma lactic dehydrogenase elevating agent of mice: Distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can. J Microbiol 1963; 9: 75–86
   Google Scholar
• Plagemann PGW, Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res 1992; 41: 99–192
   PubMed Web of Science ®Google Scholar
• Plagemann P.G.W., Rowland R.R.R., Even C., Faaberg K. S. Lactate dehydrogenase-elevating virus-an ideal persistent virus?. Semin Immunopathol 1995; 17: 167–186
   Google Scholar
• Riley V., Lilly F., Huerto E., Bardell D. Transmissible agent associated wih 26 types of experimental neoplasms. Science 1960; 132: 545–547
   Google Scholar
• Stroop W. G., Brinton M. G. Mouse-strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection. Lab Invest 1983; 49: 344–345
   Google Scholar
• van den Broek M. T., Spöric R., Even C., Plagemann P.G.W., Hänseler E., Hengartner H., Zinkernagel R. M. Lactate dehydrogenase-elevating virus (LDV). Lifelong coexistence of virus and LDV-specific immunity. J Immunol 1997; 159: 1585–1588
   Google Scholar